26-A-12343-ACC CARDIOVASCULAR BENEFITS OF TELMISARTAN IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Liver Disease Diagnosis and Treatment
Cardiovascular Function and Risk Factors
Diabetes
Cardiovascular Risks
and Lipoproteins
Publication details
- Journal / source
- Journal of the American College of Cardiology
- Volume
- 87
- Issue
- 13
- Pages
- A270–A270
- Publication date
- 27 March 2026
- Language
- EN